Skip to main content
ECAT
NYSE Unknown

Activist Saba Capital Amends Board Nominee Slate, Reports $2.56M in Share Sales

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$15.14
Mkt Cap
0
52W Low
$13.35
52W High
$17.14
Market data snapshot near publication time

summarizeSummary

Activist investor Saba Capital Management updated its board nominations for BlackRock ESG Capital Allocation Term Trust and reported recent share sales totaling $2.56 million.


check_boxKey Events

  • Updated Board Nominee Slate

    Saba Capital Management withdrew one Class III nominee (Kim Schawbel) and nominated three new individuals: Lawrence Epstein (Class I), Wayne Threatt (Class III), and Lihong Wang (Class III) for the company's board.

  • Reported Share Sales

    Saba Capital sold 169,301 shares for a total of approximately $2.56 million between February 19 and February 25, 2026.

  • Continuation of Activist Campaign

    This filing marks a continuation and modification of Saba Capital's activist efforts, following its previous nomination of a full slate of trustees on February 19, 2026, and earlier share reductions.


auto_awesomeAnalysis

Activist investor Saba Capital Management, holding a 23.73% stake, has filed an amendment to its Schedule 13D, updating its slate of nominees for the company's board. This filing withdraws one previously proposed nominee and introduces three new Class I and Class III nominees. This action continues Saba Capital's ongoing activist campaign, which previously included the nomination of a full slate of trustees on February 19, 2026. Additionally, the filing reports that Saba Capital sold approximately $2.56 million worth of shares between February 19 and February 25, 2026. This indicates a continued push for board representation while also adjusting its position.

At the time of this filing, ECAT was trading at $15.14 on NYSE in the Unknown sector. The 52-week trading range was $13.35 to $17.14. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ECAT - Latest Insights

ECAT
May 21, 2026, 5:00 PM EDT
Filing Type: DEFA14A
Importance Score:
9
ECAT
May 13, 2026, 4:23 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
May 12, 2026, 4:29 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
May 11, 2026, 5:27 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
ECAT
May 07, 2026, 10:02 AM EDT
Filing Type: DFAN14A
Importance Score:
8
ECAT
Apr 27, 2026, 6:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
ECAT
Apr 14, 2026, 4:40 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
Apr 03, 2026, 1:22 PM EDT
Filing Type: DEFC14A
Importance Score:
9
ECAT
Apr 02, 2026, 4:17 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
Mar 31, 2026, 4:27 PM EDT
Filing Type: DEFA14A
Importance Score:
8